Actualités Helix BioPharma Corp - HBP | Actions Toronto Stock Exchange

Helix Biopharma Corp. Announces Fiscal Third Quarter 2020 Results

RICHMOND HILL, Ontario, July 30, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”), a an...

Helix BioPharma Corp. Provides Update On The Timing Of Filing Of Third Quarter Results

RICHMOND HILL, Ontario, July 13, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the...

Helix BioPharma Corp. to divest remaining ownership of Polish subsidiary

RICHMOND HILL, Ontario, June 26, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the...

Proactive Virtual Event Showcases Four Rising Stars of the Life Sciences Industry

NEW YORK, June 22, 2020 (GLOBE NEWSWIRE) -- Proactive, the digital financial news organization, will be...

Helix BioPharma Corp. to Present at Proactive One2One Virtual Investor Forum

RICHMOND HILL, Ontario, June 22, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the...

Helix BioPharma Corp. Provides Update On The Timing Of Filing Of Third Quarter Results

RICHMOND HILL, Ontario, June 11, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the...

Helix BioPharma Corp. L-DOS47 Phase I Lung Cancer Trial Data to be released at ASCO 2020

RICHMOND HILL, Ontario, May 14, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the...

Helix BioPharma Corp. Provides Corporate Update

RICHMOND HILL, Ontario, April 02, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the...

HELIX BIOPHARMA CORP. ANNOUNCES FISCAL SECOND QUARTER 2020 RESULTS

RICHMOND HILL, Ontario, March 16, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”), a an...

Helix BioPharma Corp. Closes $6.0 Million Private Placement

RICHMOND HILL, Ontario, March 12, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the...

Helix BioPharma Corp. to Present at the Noble Capital Markets’ Sixteenth Annual Investor Conference

RICHMOND HILL, Ontario, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the...

Helix BioPharma Corp. Closes $3.0 Million Private Placement

RICHMOND HILL, Ontario, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the...

Helix BioPharma Corp. to Present at the Biotech Showcase Conference in San Francisco

RICHMOND HILL, Ontario, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the...

Helix BioPharma Corp. Announces Fiscal First Quarter 2020 Results

RICHMOND HILL, Ontario, Dec. 13, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”), a an...

Helix BioPharma Corp. Commences L-DOS47 Phase lb/ll Pancreatic Cancer Clinical Study

RICHMOND HILL, Ontario, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (FSE: HBP...

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Helix BioPharma Corp (HBP)

Outils de qualité professionnelle, pour des investisseurs individuels.

HBP Actualités

Helix Biopharma Corp. Announces Fiscal Third Quarter 2020 Results

Helix BioPharma Corp. Provides Update On The Timing Of Filing Of Third Quarter Results

Helix BioPharma Corp. to divest remaining ownership of Polish subsidiary

Proactive Virtual Event Showcases Four Rising Stars of the Life Sciences Industry

Helix BioPharma Corp. to Present at Proactive One2One Virtual Investor Forum

Helix BioPharma Corp. Provides Update On The Timing Of Filing Of Third Quarter Results

Helix BioPharma Corp. L-DOS47 Phase I Lung Cancer Trial Data to be released at ASCO 2020

Helix BioPharma Corp. Provides Corporate Update

HELIX BIOPHARMA CORP. ANNOUNCES FISCAL SECOND QUARTER 2020 RESULTS

Helix BioPharma Corp. Closes $6.0 Million Private Placement

Helix BioPharma Corp. to Present at the Noble Capital Markets’ Sixteenth Annual Investor Conference

Helix BioPharma Corp. Closes $3.0 Million Private Placement

Helix BioPharma Corp. to Present at the Biotech Showcase Conference in San Francisco

Helix BioPharma Corp. Announces Fiscal First Quarter 2020 Results

Helix BioPharma Corp. Commences L-DOS47 Phase lb/ll Pancreatic Cancer Clinical Study

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Vendredi fou

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Helix BioPharma Corp (HBP) Actualités

Helix BioPharma Corp (HBP)

Outils de qualité professionnelle, pour des investisseurs individuels.

HBP Actualités

Helix Biopharma Corp. Announces Fiscal Third Quarter 2020 Results

Helix BioPharma Corp. Provides Update On The Timing Of Filing Of Third Quarter Results

Helix BioPharma Corp. to divest remaining ownership of Polish subsidiary

Proactive Virtual Event Showcases Four Rising Stars of the Life Sciences Industry

Helix BioPharma Corp. to Present at Proactive One2One Virtual Investor Forum

Helix BioPharma Corp. Provides Update On The Timing Of Filing Of Third Quarter Results

Helix BioPharma Corp. L-DOS47 Phase I Lung Cancer Trial Data to be released at ASCO 2020

Helix BioPharma Corp. Provides Corporate Update

HELIX BIOPHARMA CORP. ANNOUNCES FISCAL SECOND QUARTER 2020 RESULTS

Helix BioPharma Corp. Closes $6.0 Million Private Placement

Helix BioPharma Corp. to Present at the Noble Capital Markets’ Sixteenth Annual Investor Conference

Helix BioPharma Corp. Closes $3.0 Million Private Placement

Helix BioPharma Corp. to Present at the Biotech Showcase Conference in San Francisco

Helix BioPharma Corp. Announces Fiscal First Quarter 2020 Results

Helix BioPharma Corp. Commences L-DOS47 Phase lb/ll Pancreatic Cancer Clinical Study

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Vendredi fou

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres